Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 2100.

https://doi.org/10.1182/blood-2023-173926

Published: 2023

Journal Articles

Previously Unknown Stage of TCR Beta VDJ Recombination As a Novel Rich Source of Markers for Clonality Assessment and MRD Monitoring in T-ALL

Alexander Y Komkov, Anastasia O Smirnova, Anna M Miroshnichenkova, Alexander M Popov, Alexander I Karachunskiy, Yulia V Olshanskaya, Michael A Maschan, Ilgar Z Mamedov

Blood (2021) 138 (Supplement 1): 4477.

https://doi.org/10.1182/blood-2021-146386

Published: 2021

Journal Articles

Flow Cytometry-Based Pre-Transplant Minimal Residual Disease Detection Strongly Impacts on the Outcome of Haploidentical Transplantation with Αβ T Cell Depletion in Pediatric Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 4618.

https://doi.org/10.1182/blood-2019-129792

Published: 2019

Journal Articles

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Acute Leukemia in Children

Larisa Shelikhova, MD, Rimma Khismatullina, MD, Michael Maschan, MD MSc, Alexey A. Maschan, MD, Irina Kalinina, MD, Elena Kurnikova, Yakov Muzalevsky, Alexey Kazachenok, Dmitriy Pershin, Alexander Popov, MD PhD, Galina Novichkova, MD PhD, Dmitriy Balashov, MD PhD, Daria Shasheleva, MD, Svetlana Kashpor, Evgeny Gluhanyuk

Blood (2019) 134 (Supplement_1): 150.

https://doi.org/10.1182/blood-2019-129765

Published: 2019

Journal Articles

Bruton's Tyrosine Kinase ( BTK ) Is a Novel KMT2A Partner Gene

Elena Zerkalenkova, PhD, Svetlana Lebedeva, Olga Soldatkina, Michael Maschan, MD PhD, Alexey A. Maschan, MD, Galina Novichkova, MD PhD, Yulia Olshanskaya, MD PhD

Blood (2019) 134 (Supplement_1): 5192.

https://doi.org/10.1182/blood-2019-128056

Published: 2019

Journal Articles

Novel KMT2A Partner Gene NUTM2A Revealed By Anchored Multiplex PCR in ALL

Svetlana Lebedeva, Elena Zerkalenkova, PhD, Olga Soldatkina, Michael Maschan, MD PhD, Alexey A. Maschan, MD, Galina Novichkova, MD PhD, Yulia Olshanskaya, MD PhD

Blood (2019) 134 (Supplement_1): 5203.

https://doi.org/10.1182/blood-2019-126602

Published: 2019

Journal Articles

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Blood (2019) 134 (Supplement_1): 2625.

https://doi.org/10.1182/blood-2019-130370

Published: 2019

Journal Articles

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John Grainger, MD MRCP, FRPATH, James B. Bussel, MD, Michael D. Tarantino, MD, Nichola Cooper, Donald Beam, Jenny M. Despotovic, DO, Alexey A. Maschan, MD, Kejia Wang, PhD, Melissa Jeanne Eisen, MD, Charles Bowers, MD

Blood (2019) 134 (Supplement_1): 1095.

https://doi.org/10.1182/blood-2019-131241

Published: 2019

Journal Articles

Prophylactic Antibiotic Use and Risk of Meningococcal Infections in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Eculizumab Who Received Meningococcal Vaccination: Results from the International PNH Registry

Christopher J. Patriquin, MDFRCPC,MSc, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Régis Peffault de Latour, MD PhD, Jun-Ho Jang, MD PhD, Saskia Langemeijer, MD PhD, Alexey A. Maschan, MD, Amanda Wilson, PhD, Deepak Jain, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 4802.

https://doi.org/10.1182/blood-2019-127005

Published: 2019

Journal Articles

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Michael D. Tarantino, MD, Jenny M. Despotovic, DO, MS, John Roy, John Grainger, MD MRCP, FRPATH, Nichola Cooper, MRCP, Donald Beam, Ashok Raj, Alexey A. Maschan, MD, June Kim, PhD, Melissa Jeanne Eisen, MD

Blood (2018) 132 (Supplement 1): 2428.

https://doi.org/10.1182/blood-2018-99-109763

Published: 2018

Journal Articles

Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry

Álvaro Urbano-Ispizua, MD PhD, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Marije Bartels, MD PhD, Christopher J. Patriquin, MD MSc, FRCPC, Britta Hoechsmann, MD, Alexey A. Maschan, MD, Amanda Wilson, PhD, Philippe Gustovic, MD, Hubert Schrezenmeier, MD

Blood (2018) 132 (Supplement 1): 3614.

https://doi.org/10.1182/blood-2018-99-111306

Published: 2018

Journal Articles

Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience

Olga Molostova, MD, Larisa Shelikhova, MD, Yakov Muzalevsky, Alexey Kazachenok, Dmitriy Pershin, Elena Kurnikova, Alexander Popov, MD PhD, Boro Dropulic, PhD, Dina Shneider, Rimas Orentas, PhD, Regina Alex, Mike Essl, Natalia Miakova, MD PhD, Dmitry Litvinov, MD PhD, Alexander Karachunskiy, MD PhD, Galina Novichkova, MD PhD, Alexey A. Maschan, MD, Michael Maschan, MD PhD

Blood (2018) 132 (Supplement 1): 5202.

https://doi.org/10.1182/blood-2018-99-118282

Published: 2018

Journal Articles

Replacement of Polyclonal Anti-Thymocyte Globulin By Targeted Immunomodulation Is Associated with Improved Outcome of Alfa\Beta T Cell-Depleted Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia

Blood (2018) 132 (Supplement 1): 481.

https://doi.org/10.1182/blood-2018-99-116007

Published: 2018

Journal Articles

Eltrombopag for the Treatment of Aplastic Anemia in Europe

Blood (2018) 132 (Supplement 1): 1304.

https://doi.org/10.1182/blood-2018-99-116363

Published: 2018

Journal Articles

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Pediatric Leukemia

Blood (2018) 132 (Supplement 1): 2084.

https://doi.org/10.1182/blood-2018-99-116355

Published: 2018

Journal Articles

Molecular Characteristic of Acute Leukemias with t(16;21)/Fus-Erg

Elena Zerkalenkova, PhD, Agnesa Panfyorova, PhD, Anna Kazakova, MD, Pavel Baryshev, PhD, Larisa Shelihova, MD PhD, Irina Kalinina, MD PhD, Galina Novichkova, Mikhail Maschan, PhD, Alexey A Maschan, MD PhD Professor, Yulia Olshanskaya, MD PhD

Blood (2017) 130 (Supplement 1): 5078.

https://doi.org/10.1182/blood.V130.Suppl_1.5078.5078

Published: 2017

Journal Articles

Prophylactic Treatment with New Recombinant Factor IX Innonafactor (Russia) in Adolescent and Adult Patients with Hemophilia B

Ekaterina Shiller, Victor Petrov, MD PhD, Pavel Svirin, MD, Vladimir Vdovin, MD, Igor Koltunov, MD PhD, Artyom Bullih, Michael A Maschan, Dmitry Kudlay, MD PhD Prof., Ekaterina Klykova, MD PhD

Blood (2017) 130 (Supplement 1): 4895.

https://doi.org/10.1182/blood.V130.Suppl_1.4895.4895

Published: 2017

Journal Articles

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Blood (2017) 130 (Supplement 1): 2604.

https://doi.org/10.1182/blood.V130.Suppl_1.2604.2604

Published: 2017

Journal Articles

Evolution of Platelet Function and Bleeding in Children and Adults with Chronic Immune Trombocytopenia on Romiplostim Treatment

Anastasia Ignatova, Elena Suntsova, Pavel Zharkov, Valentina Ivanova, Irina Demina, Aleksandr Poletaev, Elena Seregina, Dmitrii Polokhov, MD, Natalia Smetanina, Alexey A Maschan, MD PhD Professor, Mikhail Maschan, PhD, Galina Novichkova, Mikhail Panteleev, PhD Dr.Sc, Prof.

Blood (2017) 130 (Supplement 1): 3636.

https://doi.org/10.1182/blood.V130.Suppl_1.3636.3636

Published: 2017

Journal Articles

Changes in Leukemic Blasts CD19 Expression in Children with Relapsed/Refractory B-Cell Precursor ALL Treated with Blinatumomab

Olga Illarionova, MD, Evgeny Gluhanyuk, Svetlana Kashpor, Svetlana Plyasunova, MDPhD, Alexey A Maschan, MD PhD Professor, Natalia Miakova, MD PhD, Alexander Popov, MD PhD

Blood (2017) 130 (Supplement 1): 3991.

https://doi.org/10.1182/blood.V130.Suppl_1.3991.3991

Published: 2017

NARROW

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

Previously Unknown Stage of TCR Beta VDJ Recombination As a Novel Rich Source of Markers for Clonality Assessment and MRD Monitoring in T-ALL

Flow Cytometry-Based Pre-Transplant Minimal Residual Disease Detection Strongly Impacts on the Outcome of Haploidentical Transplantation with Αβ T Cell Depletion in Pediatric Acute Lymphoblastic Leukemia

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Acute Leukemia in Children

Bruton's Tyrosine Kinase ( BTK ) Is a Novel KMT2A Partner Gene

Novel KMT2A Partner Gene NUTM2A Revealed By Anchored Multiplex PCR in ALL

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Prophylactic Antibiotic Use and Risk of Meningococcal Infections in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Eculizumab Who Received Meningococcal Vaccination: Results from the International PNH Registry

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry

Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience

Replacement of Polyclonal Anti-Thymocyte Globulin By Targeted Immunomodulation Is Associated with Improved Outcome of Alfa\Beta T Cell-Depleted Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia

Eltrombopag for the Treatment of Aplastic Anemia in Europe

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Pediatric Leukemia

Molecular Characteristic of Acute Leukemias with t(16;21)/Fus-Erg

Prophylactic Treatment with New Recombinant Factor IX Innonafactor (Russia) in Adolescent and Adult Patients with Hemophilia B

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Evolution of Platelet Function and Bleeding in Children and Adults with Chronic Immune Trombocytopenia on Romiplostim Treatment

Changes in Leukemic Blasts CD19 Expression in Children with Relapsed/Refractory B-Cell Precursor ALL Treated with Blinatumomab

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only